Kevin E. Weddington

Array ( [id] => 9552345 [patent_doc_number] => 08759393 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Utilization of dialkylfumarates' [patent_app_type] => utility [patent_app_number] => 13/040914 [patent_app_country] => US [patent_app_date] => 2011-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3904 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13040914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8347923 [patent_doc_number] => 20120208846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'Therapeutic Methods For Type I Diabetes' [patent_app_type] => utility [patent_app_number] => 13/038127 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 39436 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13038127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9995510 [patent_doc_number] => 09040103 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-26 [patent_title] => 'Use of essential oil of oregano and of rosewood, or constituents thereof, in the therapeutic treatment of keratoses' [patent_app_type] => utility [patent_app_number] => 13/581015 [patent_app_country] => US [patent_app_date] => 2011-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 11689 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6186776 [patent_doc_number] => 20110124731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Treatment Of Neurodegenerative Diseases And Cancer Of The Brain Using Histone Deacetylase Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/017447 [patent_app_country] => US [patent_app_date] => 2011-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1959 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124731.pdf [firstpage_image] =>[orig_patent_app_number] => 13017447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6186679 [patent_doc_number] => 20110124697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'COMPOSITIONS BASED ON AMINOACIDS, SUITABLE FOR THE TREATMENT OF HEART FAILURE' [patent_app_type] => utility [patent_app_number] => 13/014294 [patent_app_country] => US [patent_app_date] => 2011-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3449 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124697.pdf [firstpage_image] =>[orig_patent_app_number] => 13014294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488501 [patent_doc_number] => 20110251396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease' [patent_app_type] => utility [patent_app_number] => 13/007956 [patent_app_country] => US [patent_app_date] => 2011-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23494 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251396.pdf [firstpage_image] =>[orig_patent_app_number] => 13007956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6037967 [patent_doc_number] => 20110091016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'POTENTIATOR FOR RADIATION THERAPY COMPRISING PYRIDINE DERIVATIVE AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 12/978743 [patent_app_country] => US [patent_app_date] => 2010-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6216 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091016.pdf [firstpage_image] =>[orig_patent_app_number] => 12978743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846322 [patent_doc_number] => 08455504 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Inhibition of the activity of the capsaicin receptor in the treatment of type 1 diabetes, type 2 diabetes, impaired glucose tolerance or insulin resistance' [patent_app_type] => utility [patent_app_number] => 12/976057 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 10887 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12976057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6118565 [patent_doc_number] => 20110076238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE PROCESSES' [patent_app_type] => utility [patent_app_number] => 12/963250 [patent_app_country] => US [patent_app_date] => 2010-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11161 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076238.pdf [firstpage_image] =>[orig_patent_app_number] => 12963250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9323657 [patent_doc_number] => 08658678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-25 [patent_title] => 'Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water' [patent_app_type] => utility [patent_app_number] => 12/928306 [patent_app_country] => US [patent_app_date] => 2010-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3559 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12928306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8406463 [patent_doc_number] => 20120238532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'TREATMENT OF HUMAN OSTEOSARCOMA' [patent_app_type] => utility [patent_app_number] => 13/512855 [patent_app_country] => US [patent_app_date] => 2010-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11933 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8653140 [patent_doc_number] => 08372889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Methods for modulating metabolism' [patent_app_type] => utility [patent_app_number] => 12/956576 [patent_app_country] => US [patent_app_date] => 2010-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 14613 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12956576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477857 [patent_doc_number] => 20120277264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'ANTITHROMBOTIC AGENT' [patent_app_type] => utility [patent_app_number] => 13/511693 [patent_app_country] => US [patent_app_date] => 2010-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3112 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5978319 [patent_doc_number] => 20110071222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'POTENTIATORS OF INSULIN SECRETION' [patent_app_type] => utility [patent_app_number] => 12/954364 [patent_app_country] => US [patent_app_date] => 2010-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3687 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071222.pdf [firstpage_image] =>[orig_patent_app_number] => 12954364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355394 [patent_doc_number] => 08673927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Uses of DPP-IV inhibitors' [patent_app_type] => utility [patent_app_number] => 12/946193 [patent_app_country] => US [patent_app_date] => 2010-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10247 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12946193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8490189 [patent_doc_number] => 20120289596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'Dermatological Compositions Comprising a Fat or Oil of an Essential Fatty Acid Triglyceride' [patent_app_type] => utility [patent_app_number] => 13/512278 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4030 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689944 [patent_doc_number] => 08389471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Amino acid composition for improving glucose tolerance' [patent_app_type] => utility [patent_app_number] => 12/942629 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7532 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12942629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944832 [patent_doc_number] => 20110105452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Oxidant Scavengers for Treatment of Diabetes or Use in Transplantation or Induction of Immune Tolerance' [patent_app_type] => utility [patent_app_number] => 12/941933 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 11799 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105452.pdf [firstpage_image] =>[orig_patent_app_number] => 12941933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944832 [patent_doc_number] => 20110105452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Oxidant Scavengers for Treatment of Diabetes or Use in Transplantation or Induction of Immune Tolerance' [patent_app_type] => utility [patent_app_number] => 12/941933 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 11799 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105452.pdf [firstpage_image] =>[orig_patent_app_number] => 12941933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071339 [patent_doc_number] => 20110046190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'COMBINATIONS COMPRISING A SELECTIVE CYCLOOXYGENASE-2 INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/938868 [patent_app_country] => US [patent_app_date] => 2010-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8328 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046190.pdf [firstpage_image] =>[orig_patent_app_number] => 12938868 [rel_patent_id] =>[rel_patent_doc_number] =>)